Published in Br J Cancer on November 01, 1979
Objective measurement of therapeutic response in breast cancer using tumour markers. Br J Cancer (1991) 1.18
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data. Br J Cancer (1990) 1.07
Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers? Br J Cancer (1993) 0.92
Ability of CEA blood levels to reflect tumour burden: a study in a human xenograft model. Br J Cancer (1982) 0.85
A low pH enzyme linked immunoassay using two monoclonal antibodies for the serological detection and monitoring of breast cancer. Br J Cancer (1986) 0.85
Serum proteins as tumour markers for breast cancer. Br J Cancer (1981) 0.77
Effect of sodium butyrate on synthesis of specific proteins by human breast-carcinoma cells. Br J Cancer (1980) 0.76
Carcinoembryonic antigen (CEA) in explants of human breast cancer: comparison of immunohistochemical detection and release during short-term culture. Br J Cancer (1983) 0.75
Possible surface protein markers for breast cancer. Br J Cancer (1981) 0.75
Electroimmuno assay. Scand J Clin Lab Invest Suppl (1972) 7.52
Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med (1978) 3.00
Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet (1974) 2.30
Prognostic significance of inappropriate production of pregnancy proteins by breast cancers. Lancet (1976) 1.73
Biochemical markers in human breast cancer. Lancet (1977) 1.48
Hypothalamic-pituitary-thyroid axis in breast cancer. Lancet (1974) 1.41
Usefulness of serial serum carcinoembryonic antigen (CEA) determinations during anticancer therapy or long-term follow-up of gastrointestinal carcinoma. Cancer (1974) 1.40
Radio-immunoassay of casein in the serum of normal subjects and of patients with various malignancies. Eur J Cancer (1974) 1.38
Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress. Cancer (1974) 1.35
Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides. Cancer (1975) 1.30
Preclinical warning of recrudescent mammary cancers by pregnancy-associated alpha-macroglobulin. Br J Surg (1976) 1.30
Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen. Cancer (1977) 1.23
Evaluation of carcinoembryonic antigen in human mammary carcinoma. J Natl Cancer Inst (1973) 1.21
Carcinoembryonic antigen in management of colorectal carcinoma. Br Med J (1974) 1.18
Correlation of the blood-level of a pregnancy-associated alpha-macroglobulin with the clinical course of cancer patients. Lancet (1975) 1.06
Radioimmunoassay and saturation analysis. Tumor-associated antigens. Br Med Bull (1974) 1.00
The investigation of lactalbumin as a possible marker for human breast cancer. Eur J Cancer (1979) 0.99
HeLa cells secrete alpha subunit of glycoprotein tropic hormones. Nature (1976) 0.96
Ectopic production of human placental lactogen by human breast tumors. Cancer (1977) 0.95
The synthesis of the glycoprotein hormone alpha subunit by human breast carcinomas. Eur J Cancer (1979) 0.90
Predictive classification of human breast carcinomas based on lactalbumin synthesis. Lancet (1977) 0.90
The radioimmunoassay of human lactalbumin. Clin Chim Acta (1977) 0.89
Casein production by human breast cancer. Cancer Res (1977) 0.88
The interference of endogenous antibodies to bovine lactalbumin in the radioimmunoassay of human lactalbumin in serum. Clin Chim Acta (1978) 0.87
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science (1994) 7.10
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med (1979) 5.87
Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet (1993) 5.48
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. Lancet (1998) 4.54
Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development (1995) 4.38
Retracted First myocardial infarction in patients of Indian subcontinent and European origin: comparison of risk factors, management, and long term outcome. BMJ (1997) 4.24
Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res (1997) 4.22
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1999) 4.15
Enzyme null alleles in natural populations of Drosophila melanogaster: Frequencies in a North Carolina population. Proc Natl Acad Sci U S A (1980) 3.24
Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation (1998) 3.18
An in vitro method for assessing the plaque forming ability of oral bacteria. Arch Oral Biol (1967) 3.11
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet (2004) 3.10
Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med (2001) 2.94
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol (2006) 2.94
Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation (2001) 2.93
AHA president's letter. Circulation (1995) 2.90
A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer (1984) 2.89
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. Br J Cancer (2004) 2.87
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol (2001) 2.71
Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation (1997) 2.64
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol (1999) 2.58
Arterial versus capillary sampling for analysing blood gas pressures. BMJ (1995) 2.55
Familial breast cancer. BMJ (1994) 2.54
Uptake of screening and prevention in women at very high risk of breast cancer. Lancet (2001) 2.45
Blindness after treatment for malignant hypertension. Br Med J (1979) 2.39
Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. J Clin Oncol (1997) 2.39
Perception of risk in women with a family history of breast cancer. Br J Cancer (1993) 2.32
Characterization of motifs which are critical for activity of the cyclic AMP-responsive transcription factor CREB. Mol Cell Biol (1991) 2.27
The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology (1995) 2.27
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet (2003) 2.24
Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet (1980) 2.19
AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association. Circulation (2000) 2.16
Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538). AIDS (1996) 2.14
Effects of exercise during long-term support with a left ventricular assist device. Results of the experience with left ventricular assist device with exercise (EVADE) pilot trial. Circulation (1997) 2.06
Transcriptional profiling reveals strict boundaries between hippocampal subregions. J Comp Neurol (2001) 1.98
The surgical management of nontraumatic ectopic lenses. J Pediatr Ophthalmol Strabismus (1996) 1.91
Linear IgA disease of adults: association with lymphoproliferative malignancy and possible role of other triggering factors. Br J Dermatol (1990) 1.91
Conceptualisation, development, and evaluation of a measure of unplanned pregnancy. J Epidemiol Community Health (2004) 1.89
Human serum alpha 1 acid glycoprotein reduces uptake, intracellular concentration, and antiviral activity of A-80987, an inhibitor of the human immunodeficiency virus type 1 protease. Antimicrob Agents Chemother (1996) 1.89
Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1. Mol Endocrinol (1994) 1.89
High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy. Breast Cancer Res Treat (2001) 1.88
Comprehensive management of children on a paediatric ward: a family approach. Arch Dis Child (1980) 1.86
Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat (1999) 1.84
Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer (1991) 1.83
An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences. J Virol (1994) 1.81
Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years. Br J Cancer (2007) 1.80
Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab (1997) 1.79
A study of plasma proteins in the sol phase of sputum from patients with chronic bronchitis. Thorax (1979) 1.79
Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol (1995) 1.76
The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer (1994) 1.75
Pathogenicity of avian malaria in experimentally-infected Hawaii Amakihi. J Wildl Dis (2000) 1.75
Demonstration and implications of lysozyme and immunoglobulins in human ear wax. Nature (1971) 1.70
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer (2001) 1.70
Alpha,-antitrypsin and leukocyte elastase in infected and noninfected sputum. Am Rev Respir Dis (1979) 1.69
Treatment of advanced prostatic cancer with LHRH analogue ICI 118630: clinical response and hormonal mechanisms. Lancet (1983) 1.69
Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. J Immunol (2000) 1.68
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer. Eur J Cancer (1996) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Mol Pharmacol (1992) 1.65
The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer (1989) 1.65
A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation (1996) 1.64
Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction. Eur Heart J (1999) 1.64
Odontomyces viscosus, gen. nov., spec. nov., a filamentous microorganism isolated from periodontal plaque in hamsters. Sabouraudia (1965) 1.61
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond) (2010) 1.61
The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas. Int J Cancer (1984) 1.61
American Heart Association Report on the Public Access Defibrillation Conference December 8-10, 1994. Automatic External Defibrillation Task Force. Circulation (1995) 1.60
Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast. J Natl Cancer Inst (1997) 1.58
Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol (2007) 1.57
Transcriptional regulation of the human insulin gene is dependent on the homeodomain protein STF1/IPF1 acting through the CT boxes. Proc Natl Acad Sci U S A (1994) 1.56
Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet (1984) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Design of a safer approach to intravenous drug infusions: failure mode effects analysis. Qual Saf Health Care (2004) 1.55
Activation of the human immunodeficiency virus by herpes simplex virus type 1. J Virol (1987) 1.55
Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia (1998) 1.52
A filamentous microorganism isolated from periodontal plaque in hamsters. 1. Isolation, morphology and general cultural characteristics. Sabouraudia (1963) 1.52
Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol (1991) 1.50